Provided by Tiger Trade Technology Pte. Ltd.

BEONE MEDICINES

213.600
-1.800-0.84%
Volume:718.20K
Turnover:153.77M
Market Cap:329.37B
PE:143.40
High:216.400
Open:215.400
Low:212.400
Close:215.400
52wk High:235.600
52wk Low:153.000
Shares:1.54B
HK Float Shares:1.43B
Volume Ratio:1.47
T/O Rate:0.05%
Dividend:- -
Dividend Rate:- -
EPS(LYR):1.490
ROE:14.66%
ROA:7.46%
PB:8.12
PE(LYR):143.40
PS:6.86

Loading ...

Hong Kong Stock Connect Biotech Sector Extends Over 8-Month Slump, Key ETF Hits Record Low

Deep News
·
May 28

Movement Alert|BeiGene Declines 3.21% in Regular Trading, Trading at HK$175.1

Market Focus
·
May 28

Market Chatter: China Approves 15 Domestic Innovative Drugs

MT Newswires Live
·
May 28

Movement Alert|BeiGene Declines 3.07% in Regular Trading, Trading at HK$182.5

Market Focus
·
May 27

BUZZ-J&T Global Express leads gain in newcomers to Hang Seng Index

Reuters
·
May 26

Hang Seng Index Quarterly Review Boosts Industrial and Healthcare Sector Coverage; Six Stocks May Enter Southbound Trading

Stock News
·
May 25

Hang Seng Index Quarterly Review Results Announced: New Additions Include J&T Express, BeiGene, and CHALCO

Deep News
·
May 22

Zhipu and MiniMax Poised for Inclusion in Hang Seng Tech Index

Deep News
·
May 22

Movement Alert|BeiGene Rises 3.48% in Regular Trading, Q1 Earnings Beat Expectations as Multiple Banks Raise Outlook

Market Focus
·
May 21

Movement Alert|BeiGene Rises 3.15% in Regular Trading, Q1 Earnings Beat Expectations as Major Banks Collectively Raise Outlook

Market Focus
·
May 20

BEIGENE Shares Rise Nearly 3% on FDA Accelerated Approval for Sotoklara and Strong Q1 Earnings Beat

Stock News
·
May 20

Major Financial Institutions Bullish on BEIGENE, Q1 Performance Confirms Long-Term Investment Value

Stock News
·
May 19

BEIGENE's BEQALZI™ Secures FDA Accelerated Approval as First and Only BCL2 Inhibitor for Relapsed/Refractory Mantle Cell Lymphoma in the U.S.

Stock News
·
May 14

BEIGENE Announces Grant of Restricted Stock Units

Stock News
·
May 13

BeOne Announces US$7.94 Million RSU Grant Covering 0.02% of Share Capital

Bulletin Express
·
May 13

BEIGENE Reports Q1 Profit Turnaround with 1.6 Billion Yuan Net Income

Stock News
·
May 11

Market Outlook: Hong Kong Stocks Rebound as Expected, Awaiting Multiple Catalysts

Stock News
·
May 11

CICC Maintains Outperform Rating on BEIGENE with HK$250 Target Price

Stock News
·
May 08

Leadership Reshuffle Sweeps Pharmaceutical Sector: Hengrui, Fosun, AstraZeneca, Pfizer Among Key Players

Deep News
·
May 07

BEIGENE's Q1 Net Profit Soars 399% Sequentially, Shares Jump 7% Post-Earnings

Deep News
·
May 07